Multi-target agreement with Top10 pharma company

Salipro Biotech enters multi-target agreement with additional Top10 pharma company to advance programs using the Salipro® platform on challenging drug targets selected by the pharmaceutical partner.

Previous
Previous

Study published in Nature using Salipro®

Next
Next

Salipro Biotech presents at Biologics Series 2020